Shock Flashcards

1
Q

Evidence of cardiovascular organ compromise

A

Cardiac index < 2.2
SBP < 90
MAP < 65

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Signs of hypoperfusion

A

Cold, clammy, mottled skin
lactate > 2
Scvo2 < 65%
Svo2 < 60%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

signs of organ dysfunction

A

encephalopathy
lethargy
confusion
urine output < 0.5 mL/kg/hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Blood pressure

A

CO x SVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cardiac output

A

HR x SV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Stroke volume

A

preload
intrinsic contractility
afterload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mean arterial pressure

A

1/3 SBP + 2/3 DBP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hypovolemic shock

A

inappropriately low and sudden loss of intravascular volume:
- blood loss
- GI loss
- severe dehydration
- burns

decreased volume -> decreased preload -> decreased CO
Compensation: increase in SVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hypovolemic shock management

A

Replace fluids
- crystalloids
- occasionally albumin

Hemorrhage:
- replace blood (PRBCs)
- anticoagulation reversal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cardiogenic shock

A

LV failure (pump failure)
MI
Arrhythmia
Heart failure
Dilated cardiomyopathy

impaired emptying of left ventricle -> decreased CO -> fluid backup in pump -> preload increases
Compensation: increased SVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cardiogenic shock management

A

MI:
- revascularization CABV
Arrhythmia:
- achieve sinus rhythm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Distributive shock

A

pronounced vasodilation “vasodilatory shock”
Sepsis
anaphylaxis
neurogenic
myxedema coma (thyroid deficiency)
adrenal insufficiency
hepatic insufficiency

vasodilation -> reduced SVR -> decreased vol returning to heart -> decreased preload
Compensation: HR increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Obstructive shock

A

obstruction in LV preventing pushing blood out
- pulmonary embolism
- severe pulmonary hypertension
- tension pneumothorax
- pericardial tamponade

decreased LV stroke volume -> decrease in CO and tissue perfusion
preload will appear high due to obstruction
Compensation: increased SVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Goal MAP in shock treatment

A

> 65

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fluid therapy

A

Crystalloids 30 mL/kg over 15-30 min then 10 mL/kg boluses

Cardiogenic shock : 100-200 mL boluses

increase SV, CO, DO2
initiate vasoactive agent when MAP remains < 65 despite fluid admin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Vasopressors

A

Norepinephrine
Epinephrine
Dopamine
Phenylephrine
Vasopressin

17
Q

Norepinephrine

A

Alpha adrenergic agonist - increases MAP via peripheral vasoconstriction
preferred over dopamine in septic shock
- less risk of arrhythmias
- improves renal blood flow
ADE
- significant vasoconstriction

18
Q

Epinephrine

A

potent alpha and beta adrenergic agonist
Low dose -> beta effects -> inc HR, SV, and b2 vasodilation
High dose -> alpha effects
useful for anaphylactic shock
in septic shock, 2nd line after norepinephrine
ADE
- tachycardia
- arrhythmias
- cardiac ischemia
- peripheral vasodilation
- reduced renal blood flow
- hyperglycemia
- hypokalemia

19
Q

Dopamine

A

Most effective in hypotensive pts with decreased cardiac function
useful in pts with bradycardia

low dose: dopaminergic
- vasodilation of renal, mesenteric, and coronary
- increases renal blood flow, GFR, and sodium excretion

Med dose: beta adrenergic
- increase cardiac contractility and HR
- increase norepi release form nerve terminals

High dose: alpha adrenergic
- arterial vasoconstriction

ADE:
- tachycardia
- arrythmias
- peripheral vasoconstriction

20
Q

Phenylephrine

A

Alpha 1 adrenergic agonist
not recommended in septic shock unless:
- NE produces significant tachyarrhythmias
- cardiac output is high and BP is persistently low
- salvage therapy when standard therapies are ineffective
ADE
- severe vasoconstriction
- bradycardia
- myocardial ischemia

21
Q

Dobutamine

A

Inotrope - increased cardiac contractility
added to treatment of shock when cardiac output of SVO2 / SCVO2 goals have not been achieved with vasopressor therapy

often used for cardiogenic shock

22
Q

Vasopressin

A

ADH
Relative deficiency in septic shock
Dose: 0.3 U/min
should not be used as the sole vasopressor in sepsis
ADE
- cardiac and mesenteric ischemia